We are live on ! Find out more
INDP icon

Indaptus Therapeutics

14 hedge funds and large institutions have $10.5M invested in Indaptus Therapeutics in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more capital invested

Capital invested by funds: $4.24M → $10.5M (+$6.23M)

0.44% more ownership

Funds ownership: 0.36%0.8% (+0.44%)

0% more funds holding

Funds holding: 1414 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
14
Holders Change
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

INDP Hedge Fund Activity: Q4 2021 in Review

14 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q4 2021, worth a combined $10.5M — up 147% from $4.24M a quarter earlier.

Fund positioning in INDP was balanced in Q4 2021: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 0 trimmed.

The largest buyer was Stratos Wealth Partners, opening a new position worth an estimated $9.21M. The largest seller was Armistice Capital, exiting entirely with an estimated $2.99M sold.

  • 14 institutional investors held Indaptus Therapeutics (INDP) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $10.5M of Indaptus Therapeutics stock for Q4 2021, up 147% quarter-over-quarter.
  • 4 funds opened new Indaptus Therapeutics positions in Q4 2021 and 4 closed out, a net change of 0 holders.
  • The largest Indaptus Therapeutics buyer in Q4 2021 was Stratos Wealth Partners, an estimated $9.21M added.
  • The largest Indaptus Therapeutics seller in Q4 2021 was Armistice Capital, an estimated $2.99M sold.

Based on aggregated 13F filings for Q4 2021.